多层螺旋CT三维重建对肝癌介入治疗的应用价值

目的 探讨多层螺旋CT血管三维重建对肝癌TACE治疗的价值.方法 选取60例首次TACE术前经MSCT血管重建的原发性肝癌患者作为研究组,60例首次TACE术前未经MSCT血管重建的原发性肝癌患者作为对照组,观察MSCT对肝癌异位血管的显示,比较TACE术后两组患者的预后和生存情况.结果 研究组和对照组中位生存期分别为537.5、348.5天.研究组前两次介入时间间隔明显长于对照组（88.7vs65.4天,P＜0.05）,3年生存率也明显高于对照组（19％ vs 6％,P＜0.05）.结论 多层螺旋CT血管重建技术有利于提高肝癌介入治疗的疗效,可作为肝癌TACE术前的常规检查.

Applications of MSCT Vascular Reconstruction for the Interventional Treatment of Hepatic Carcinoma

Objective To explore the value of multi-slice spiral CT （MSCT） vascular reconstruction for the transcatheter arterial chemoembolization （TACE） therapy of hepatic carcinoma.Methods Totally 60 patients with primary hepatic carcinoma who had done MSCT vascular reconstruction before the first time of transcatheter arterial chemoembolization （TACE） were selected as study group,and another 60 patients who had not done MSCT vascular reconstruction before treatment were as control group.The display of the hepatic ectopia vessels was observed under MSCT,and the prognosis and survival condition between the two groups was compared.Results The median survival for study group and control group was 537.5,348.5 days respectively.The former two interventions interval of the study group came out longer than the control group＇s apparently（88.7 vs 65.4 days,P 〈 0.05）,and the 3 years survival rates came to be higher than the control group as well（19% vs 6%,P 〈 0.05）.Conclusion The multi-slice spiral CT vascular reconstruction technology is confirmed to be benefit for improving the efficacy of interventional treatment of hepatic carcinoma,and can be adopted as a routine examination before TACE for the liver cancers.